GABAA receptors mediate the attenuating effects of a 5-HT 3 receptor antagonist on methamphetamine-induced behavioral sensitization in mice

Synapse

Volumn 64, Issue 4, 2010, Pages 274-279

  Yoo, Ji Hoon ^a   Lee, Ha Kyung ^b   Kim, Hyoung Chun ^c   Lee, Seok Yong ^b   Jang, Choon Gon ^b  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b Sungkyunkwan University   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

Apomorphine; Autoradiography; Benzodiazepine; Dopamine; MDL72222; Raclopride; SCH23390

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; APOMORPHINE; BEMESETRON; BENZODIAZEPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; FLUNITRAZEPAM; METHAMPHETAMINE; SEROTONIN 3 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GABAERGIC SYSTEM; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION;

AMPHETAMINE-RELATED DISORDERS; ANALYSIS OF VARIANCE; ANIMALS; APOMORPHINE; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; BENZAZEPINES; BRAIN MAPPING; DOPAMINE AGONISTS; DRUG INTERACTIONS; FLUNITRAZEPAM; GABA MODULATORS; MALE; METHAMPHETAMINE; MICE; MICE, INBRED ICR; MOTOR ACTIVITY; PROTEIN BINDING; RACLOPRIDE; RECEPTORS, GABA-A; SEROTONIN ANTAGONISTS; TRITIUM; TROPANES;

EID: 73449111592     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20726     Document Type: Article

References (26)

1. 3H]spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity. Biol Psychiatry 17:223-231.
2. Armstrong BD, Noguchi KK. 2004. The neurotoxic effects of 3,4-methylenedioxymethamphetamine (MDMA) and methamphetamine on serotonin, dopamine, and gaba-ergic terminals: An invitro autoradiographic study in rats. Neurotoxicology 25:905-914.
3. Burrows KB, Meshul CK. 1999. High-dose methamphetamine treatment alters presynaptic GABA and glutamate immunoreactivity. Neuroscience 90:833-850.
4. Gatch MB, Selvig M, Forster MJ. 2005. GABAergic modulation of the discriminative stimulus effects of methamphetamine. Behav Pharmacol 16:261-266.
5. Gerasimov MR, Ashby CR Jr, Gardner EL, Mills MJ, Brodie JD, Dewey SL. 1999. Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine. Synapse 34:11-19.
6. 2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis. Brain Res. 546:40-46.
7. Ito K, Ohmori T, Abekawa T, Koyama T. 2000. The role of benzodiazepine receptors in the acquisition and expression of behavioral sensitization to methamphetamine. Pharmacol Biochem Behav 65:705-710.
8. Kitanaka N, Kitanaka J, Takemura M. 2003. Behavioral sensitization and alteration in monoamine metabolism in mice after single versus repeated methamphetamine administration. Eur J Pharmacol 474:63-70.
9. Mansour A, Meador-Woodruff JH, Bunzow JR, Civelli O, Akil H, Watson SJ. 1990. Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: An in situ hybridization- receptor autoradiographic analysis. J Neurosci 10:2587-2600.
10. Matsumoto M, Kanno M, Togashi H, Ueno K-I, Otani H, Mano Y, Yoshioka M. 2003. Involvement of GABAA receptors in the regulation of the prefrontal cortex on dopamine release in the rat dorsolateral striatum. Eur J Pharmacol 482:177-184.
11. 2 dopamine receptors as evidenced by autoradiography: Comparison with tyrosine hydroxylase activity. Neuroscience 23:253-261.
12. 3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon. J Neurosci 17:3157-3167.
13. Morales M, Battenberg E, de Lecea L, Bloom FE. 1996. The type 3 serotonin receptor is expressed in a subpopulation of GABAergic neurons in the rat neocortex and hippocampus. Brain Res 731:199-202.
14. A receptor γ2 subunit gene (GABRG2) and methamphetamine use disorder. Pharmacogenomics J 5:89-95.
15. 1-dopamine receptor ligand, in the rat brain. Neurosci Lett 120:109-112.
16. Oh S, Jang C-G, Ma T, Ho IK. 1999. Activation of protein kinase C by phorbol dibutyrate modulates GABAA receptor binding in rat brain slices. Brain Res 850:158-165.
17. 2 receptors in the forebrain of dystonia musculorum mutant mice: An autoradiographic survey in relation to dopamine contents. Synapse 37:1-15.
18. Pierce RC, Kalivas PW. 1997. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25:192-216.
19. Pierce RC, Kumaresan V. 2006. The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev 30:215-238.
20. Stefanski R, Ladenheim B, Lee SH, Cadet JL, Goldberg SR. 1999. Neuroadaptations in the dopaminergic system after active self-administration but not after passive administration of methamphetamine. Eur J Pharmacol 371:123-135.
21. Ujike H, Onoue T, Akiyama K, Hamamura T, Otsuki S. 1989. Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology (Berl) 98:89-92.
22. Woo S-H, Kim H-S, Yun J-S, Lee M-K, Oh K-W, Seong Y-H, Oh S-K, Jang C-G. 2001. Inhibition of Baclofen on morphine-induced hyperactivity, reverse tolerance and postsynaptic dopamine receptor supersensitivity. Pharmacol Res 43:335-340.
23. 3A receptor channel and binding study. J Neurochem 99:976-988.
24. Yoo JH, Nam YS, Lee SY, Jang CG. 2008. Dopamine neurotransmission is involved in the attenuating effects of 5-HT3 receptor antagonist MDL 72222 on acute methamphetamine-induced locomotor hyperactivity in mice. Synapse 62:8-13.
25. Yoo JH, Yang EM, Lee SY, Loh HH, Ho IK, Jang CG. 2003. Differential effects of morphine and cocaine on locomotor activity and sensitization in l-opioid receptor knockout mice. Neurosci Lett 344:37-40.
26. 67 expression. Biochem Biophys Res Commun 351:300-305.